| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.27 | 0.007 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |